Non-Performing Assets / Total Loans (Annual)

Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made

PTC Therapeutics, Inc. (PTCT) Non-Performing Assets / Total Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$1.73B
Net Income	$682.64M
Cost of Goods Sold	$47.01M
Gross Profit	$1.68B
Operating Expenses	$863.72M
Operating Income	$866.93M
Non-Operating Income/Expense	$-170.32M
Pre-Tax Income	$696.62M
Normalized Pre-Tax Income	$696.62M
Income after Taxes	$682.64M
Income from Continuous Operations	$682.64M
Consolidated Net Income/Loss	$682.64M
Normalized Income after Taxes	$682.64M
EBIT	$866.93M
EBITDA	$888.95M
Weighted-Average Shares Outstanding (Basic)	79.53M
Weighted-Average Shares Outstanding (Diluted)	88.31M
Earnings per Share (EPS) (Basic)	$8.58
Earnings per Share (EPS) (Diluted)	$7.78
Balance Sheet Financials
Current Assets	$2.27B
Property, Plant, and Equipment	$55.37M
Long-Term Assets	$624.82M
Total Assets	$2.90B
Current Liabilities	$968.43M
Long-Term Debt	$2.03B
Long-Term Liabilities	$2.14B
Total Liabilities	$3.10B
Common Equity	$-205.31M
Tangible Shareholders Equity	$-676.41M
Shareholders Equity	$-205.31M
Common Shares Outstanding	81.47M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$711.20M
Cash Flow from Investing Activities	$-861.98M
Cash Flow from Financial Activities	$331.09M
Beginning Cash	$795.32M
End Cash	$998.33M
Increase/Decrease in Cash	$203.02M
Stock-Based Compensation	$74.55M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.11
Debt to Equity Ratio	-12.67
Gross Margin	97.28%
Operating Margin	50.09%
EBIT Margin	50.09%
EBITDA Margin	51.36%
Pre-Tax Profit Margin	40.25%
Profit Margin	39.44%
Free Cash Flow	$702.41M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.60
Inventory Turnover	0.59
Receiveable Turnover	9.53
Days Sales in Receivables	38.30
Return on Equity	-332.49%
Return on Tangible Equity	-100.92%
Return on Assets	23.55%
Return on Investments	37.45%
Book Value Per Share	$-2.52
Free Cash Flow per Share	$7.95
Operating Cash Flow per Share	$8.05

Data from Zacks Investment Research, Inc.